Christine Pamela Bump

Co-Presenter, "Untangling Uncertainty: What's Next in Clinical Lab Compliance?"

Panelist, "Adapting to Payer Policy Shifts: Ensuring Compliance and Reimbursement"

Panelist, "Where Are My Samples? Deconvoluting Biospecimen Supply Chain Logistics"

"FDA Regulation of LDTs: The Impact on Clinical Trials for Precision Medicine"

Beyond the LDT Ruling: Next Steps and What it Means for Your Lab

"The Impact of PAMA, SALSA, and CLIA on Today's Diagnostic Landscape"

Panelist, "FDA's Final Rule Vacated: What's Next for Your Lab?"

FDA's LDT Rule: Are You Ready? (Co-Presenter)

Co-Presenter, "AI Meets LDT: Navigating the New Frontier of Clinical Diagnostics"

"Loper Bright and the Potential Impact on the Laboratory Industry"

"FDA's Final LDT Rule: Settting Priorities and Next Steps in Your Lab"

"Dissecting FDA's Proposed Rule Governing LDTs & Effect on Laboratories"

Panelist, "Analyzing Specifications in the FDA Final Rule for Lab Developed Tests"

"Dissecting FDA's Final Rule Governing LDTs & Effect on Laboratories"

"Dissecting FDA's Proposed Rule Governing LDTs & Effect on Laboratories"

"FDA's Intent to Reclassify IVDs: What it Means and What Labs Need to Know"

"FDA's Final Rule on LDTs: What This Means for Laboratories"

"FDA's Quality Management System Regulation: What Laboratories Need to Know"

"What Post-Marketing Issues Should I Be Considering?"

Panelist, "Impact of FDA Final Rule Regulating Lab Diagnostic Tests on Cancer Care"

"A Deep Dive into Medical Device Regulatory Strategy"

"Telemedicine and Remote Patient Monitoring: Public Health Emergency Expiration Next Steps & Associated Costs"

"Dissecting FDA's Proposed Rule Governing LDTs & Effect on Laboratories"

"Dissecting the VALID Act"

Moderator, “Preparing for the Next Public Health Crisis: Implementing a Culture-Centered Approach to Collaborative Communication Efforts by the FDA and CDC"

"Dissecting the VALID Act"

"What Post-Marketing Issues Should I Be Considering?"

"Digital Health: Enforcement, Regulations, and Risks"

"Presenting Risk Information in Promotional Materials & Good Reprint Practices"

"Premarket Notification, 510(k)"

"Legal and Industry Perspectives of FDA's Regulation of Medical Devices"

"IVDMIAs: Is FDA Changing How Laboratories Operate?"